CLINICAL_TRIALS
trial_result
· 2012-09-11
Clinical Trial Update: Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 long-term safety trial of z102 in combination with prednisone for moderate to severe rheumatoid arthritis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zalicus | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED